This Lab Confirmation Testing Kit market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study.
This study is one of the most comprehensive documentation that captures all the facets of the evolving Lab Confirmation Testing Kit market.
COVID-19, also known as coronavirus disease, is continuing to spread globally with confirmed cases now surpassing 9,60,000 cases. With skyrocketing confirmed incidences of COVID-19, pharma, healthcare workers, universities as well as institutes are working tirelessly day and night to discover or develop cure for the life-threatening virus.
A point of contention at this critical hour is testing rates. It is only through widespread testing that the spread of this lethal virus and other metrics such as infectiousness and mortality rates, can be effectively recorded. Thus, readily available test kits are an indispensable way of effectively fighting and curbing the pandemic.
Aiming to identify research gaps and priorities for COVID-19, collaborating with GloPID-R, WHO has organized a Forum on 11-12 February, 2020. The Forum has recognized urgent need for access to accurate and standardized diagnostics for SARS-CoV-2 (the causative agent of COVID-19), deployable in decentralized settings, has been recognized as one of the eight immediate research needs.
The Centers for Disease Control and Prevention (CDC), the US agency charged with tracking and investigating public health trends, is working in close co-operation with private labs to make more tests available. According to health experts, such an initiative would help capacitate to complete about 100 tests per day, which isn’t proportionate to the spread of this virus.
At this point of time, an effective and efficient diagnosis of this alarmingly spreading virus would immensely help in curbing its spread all around the world.
Developing a widely accessible, inexpensive point-of-care diagnostic kit requires an accountable leadership, decisive science-based governance, significant financing, and the application of reliable principle-based scientific protocols to determine whom to test, how to interpret results, and how best to treat and quarantine those infected.
Such measures would not only help contain the current COVD-19 epidemic; it can also create a system for developing similar tools to stop future pandemics. Thus, by taking the lead in creating such an infrastructure, the US can help itself and the rest of the world as well. According to Mediheroes, made-in-Korea diagnostic kits that have not won FDA’s emergency use authorization are likely to be used in USA.
Numerous companies are racing to develop diagnostic kits – a new diagnostic tools identified by the Foundation for Innovative Diagnostics, a fifteen-minute test being developed by Chinese laboratories, a Duke University test being deployed in Singapore and diagnostic tests by CRISPR technology are a few noteworthy mentions.
The US Food and Drug Administration (FDA) has an accelerated pathway for “emergently needed” diagnostic tools, but relies on developers need to conduct or sponsor themselves.
While in majority cases, patients experience minor symptoms, the disease can cause death under severe cases. Thus, medical companies worldwide are leaving no stones unturned to manufacture diagnostic kits for the alarmingly spreading coronavirus
In partnership with the Institut Pasteur de Dakar, manufacturing of the test kits will happen at DiaTropix, a new custom-built facility for epidemics-related innovation, in Dakar, Senegal. The current, long-winding process for testing for corona infections involve a throat swab, transporting samples to laboratories with test kits and wait for upto 24hours for the results.
Mologic had earlier created test kits for measles, Ebola and yellow fever. The lab confirmation test kits created by Mologic would be validated by specialists in the Liverpool School of Tropical Medicine, the Wuhan Institute of Virology, the London University, the University of Malaya, Malaysia and Fiocruz in Brazil. A successfully developed and validated, a much faster way to test and diagnose Covid-19 could prove critical at this hour of crisis.
The brain of Bosch Healthcare Solutions subsidiary and the Northern Irish medical technology company, Randox Laboratories Ltd. is Bosch’s rapid COVID-19 test. This brand-new, fully automated test is expected to aid medical facilities - doctors, laboratories, hospitals, healthcare centers - diagnose faster.
To quote Dr. VolkmarDenner, chairman of the board of management of Robert Bosch GmbH, “We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up identification and isolation of infected patients”.
Bosch’s rapid COVID-19 test delivered result with an accuracy of over 95 percent when tested in various laboratories with SARS-CoV-2. The most unique feature of Bosch Vivalytic analyzer is that it can perform up to 10 tests in 24 hours; meaning only 100 devices can evaluate up to 1000 tests per day.
Bosch’s rapid test can detect a SARS-CoV-2 coronavirus infection in just two and a half hours (includes the time the sample is taken to the time the result arrives). The ability of the test being performed at the point of care itself is an added boon. It is in talks that these newly developed tests will be available in Germany in April, with emerging markets in Europe and elsewhere.
Broadening the criteria for testing, India has asked every state to designate atleast one hospital for treating COVID-19 cases. Apart from the 116 government labs that were approved for testing, testing approval was granted to private labs across three states – Thryocare; Metropolis Healthcare and Suburban Diagnostics in Mumbai, Maharashtra, Unipath Specialty Laboratory Ltd. in Ahmedabad, Gujarat and NeubergAnand Reference Laboratory in Bengaluru, Karnataka. Mumbai’s Sir H. N. Reliance Foundation Hospital and Research Centre, run by MukeshAmbani, has also been granted approval for the testing.
On the basis of Modularity, Lab Confirmation Testing Kit Market is segmented into:
On the basis of end use, Lab Confirmation Testing Kit Market segmented into:
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Soil Testing Kit Market Growth - Trends & Forecast 2025 to 2035
Lab Screening Test Kit Market
Water Testing Kit Market Analysis by Product, Test Type, Water Type, End User, and Region - Analysis for 2025 to 2035
Fungal Testing Kits Market Analysis – Size, Trends & Forecast 2025 to 2035
Cortisol Testing Kits Market Size and Share Forecast Outlook 2025 to 2035
Oxytocin Testing Kits Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Rapid RNA Testing Kits Market Trends- Growth & Forecast 2025 to 2035
Irrigation testing kit Market
Demand for Water Testing Kit in Japan Size and Share Forecast Outlook 2025 to 2035
Respiratory Pathogen Testing Kits Market Insights - Growth & Forecast 2025 to 2035
Paediatric & Neonatal Testing Kits Market – Growth & Forecast 2025 to 2035
Lab Emulsifier Market Size and Share Forecast Outlook 2025 to 2035
Laboratory Precision Oven Market Size and Share Forecast Outlook 2025 to 2035
Labels Market Forecast and Outlook 2025 to 2035
Laboratory Information System Market Forecast and Outlook 2025 to 2035
Label Applicators Market Size and Share Forecast Outlook 2025 to 2035
Lab Mailers Market Size and Share Forecast Outlook 2025 to 2035
Kitchen/ Toilet Roll Converting Machines Market Size and Share Forecast Outlook 2025 to 2035
Kitting Robots Market Size and Share Forecast Outlook 2025 to 2035
Labor Management System In Retail Market Size and Share Forecast Outlook 2025 to 2035
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA